These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26322661)

  • 1. Can residual paralysis be avoided?: A critical appraisal of the use of sugammadex.
    Esteves S
    Eur J Anaesthesiol; 2015 Oct; 32(10):663-5. PubMed ID: 26322661
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual paralysis: a real problem or did we invent a new disease?
    Donati F
    Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Carron M; Parotto E; Ori C
    Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
    [No Abstract]   [Full Text] [Related]  

  • 4. [Residual neuromuscular blockade].
    Fuchs-Buder T; Schmartz D
    Anaesthesist; 2017 Jun; 66(6):465-476. PubMed ID: 28573344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrins and the emergence of sugammadex.
    Booij LH
    Anaesthesia; 2009 Mar; 64 Suppl 1():31-7. PubMed ID: 19222429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 8. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report.
    Ortiz-Gómez JR; Palacio-Abizanda FJ; Fornet-Ruiz I
    Eur J Anaesthesiol; 2014 Dec; 31(12):708-9. PubMed ID: 24718022
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature.
    de Boer HD; Shields MO; Booij LH
    Eur J Anaesthesiol; 2014 Dec; 31(12):715-21. PubMed ID: 25192270
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed recurarisation after sugammadex reversal.
    Bellod A; March X; Hernandez C; Villalonga A
    Eur J Anaesthesiol; 2014 Dec; 31(12):710-2. PubMed ID: 25101712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myorelaxation tactic with sugammadex in surgery with neurophysiological monitoring].
    Anesteziol Reanimatol; 2012; (4):80-1. PubMed ID: 23082654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular monitoring, residual blockade, and reversal: time for re-evaluation of our clinical practice.
    Plaud B
    Can J Anaesth; 2013 Jul; 60(7):634-40. PubMed ID: 23661296
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
    Craig RG; Hunter JM
    Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex as rescue therapy for residual neuromuscular blockade in the intensive care unit.
    Carron M; Baratto F; Pettenuzzo T; Ori C
    Can J Anaesth; 2016 Dec; 63(12):1384-1385. PubMed ID: 27646527
    [No Abstract]   [Full Text] [Related]  

  • 18. Do we need to use sugammadex at the end of a general anesthesia to reverse the action of neuromuscular bloking agents? Position Paper on Sugammadex use.
    Della Rocca G; Di Marco P; Beretta L; De Gaudio AR; Ori C; Mastronardi P
    Minerva Anestesiol; 2013 Jun; 79(6):661-6. PubMed ID: 23192221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sugammadex: a new approach to the use of neuromuscular blockers].
    Alvarez-Gómez JA; Veiga-Ruiz G
    Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():20-3. PubMed ID: 21916086
    [No Abstract]   [Full Text] [Related]  

  • 20. Adequate confirmation of recovery from neuromuscular blockade: what are the obstacles?
    Caruso L; Urdaneta F
    Can J Anaesth; 2014 Jan; 61(1):82. PubMed ID: 24203502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.